TY - JOUR
T1 - Four USH2A founder mutations underlie the majority of Usher syndrome type 2 cases among non-Ashkenazi Jews
AU - Auslender, Noa
AU - Bandah, Dikla
AU - Rizel, Leah
AU - Behar, Doron M.
AU - Shohat, Mordechai
AU - Banin, Eyal
AU - Allon-Shalev, Stavit
AU - Sharony, Reuven
AU - Sharon, Dror
AU - Ben-Yosef, Tamar
PY - 2008/6/1
Y1 - 2008/6/1
N2 - Type 2 Usher syndrome (USH2) is a recessively inherited disorder, characterized by the combination of early onset, moderate-to-severe, sensorineural hearing loss, and vision impairment due to retinitis pigmentosa. From 74% to 90% of USH2 cases are caused by mutations of the USH2A gene. USH2A is composed of 72 exons, encoding for usherin, an extracellular matrix protein, which plays an important role in the development and maintenance of neurosensory cells in both retina and cochlea. To date, over 70 pathogenic mutations of USH2A have been reported in individuals of various ethnicities. Many of these mutations are rare private mutations segregating in single families. The aim of the current work was to investigate the genetic basis for USH2 among Jews of various origins. We found that four USH2A mutations (c.239-240insGTAC, c.1000C>T, c.2209C>T, and c.12067-2A>G) account for 64% of mutant alleles underlying USH2 in Jewish families of non-Ashkenazi descent. Considering the very large size of the USH2A gene and the high number of mutations detected in USH2 patients worldwide, our findings have significant implications for genetic counseling and carrier screening in various Jewish populations.
AB - Type 2 Usher syndrome (USH2) is a recessively inherited disorder, characterized by the combination of early onset, moderate-to-severe, sensorineural hearing loss, and vision impairment due to retinitis pigmentosa. From 74% to 90% of USH2 cases are caused by mutations of the USH2A gene. USH2A is composed of 72 exons, encoding for usherin, an extracellular matrix protein, which plays an important role in the development and maintenance of neurosensory cells in both retina and cochlea. To date, over 70 pathogenic mutations of USH2A have been reported in individuals of various ethnicities. Many of these mutations are rare private mutations segregating in single families. The aim of the current work was to investigate the genetic basis for USH2 among Jews of various origins. We found that four USH2A mutations (c.239-240insGTAC, c.1000C>T, c.2209C>T, and c.12067-2A>G) account for 64% of mutant alleles underlying USH2 in Jewish families of non-Ashkenazi descent. Considering the very large size of the USH2A gene and the high number of mutations detected in USH2 patients worldwide, our findings have significant implications for genetic counseling and carrier screening in various Jewish populations.
UR - http://www.scopus.com/inward/record.url?scp=45549107998&partnerID=8YFLogxK
U2 - 10.1089/gte.2007.0107
DO - 10.1089/gte.2007.0107
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 18452394
AN - SCOPUS:45549107998
SN - 1090-6576
VL - 12
SP - 289
EP - 294
JO - Genetic Testing
JF - Genetic Testing
IS - 2
ER -